Home > Qtrly Results > DIVIS LABORATORIES

DIVIS LABORATORIES
Quarterly Results Analysis [Mar2024]

DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Revenues ₹2,303 Cr ₹1,855 Cr ₹1,909 Cr ₹1,778 Cr ₹1,951 Cr ₹1,708 Cr ₹1,855 Cr ₹2,255 Cr
Expenses ₹1,572 Cr ₹1,366 Cr ₹1,430 Cr ₹1,274 Cr ₹1,464 Cr ₹1,299 Cr ₹1,234 Cr ₹1,407 Cr
Operating Income ₹731 Cr ₹489 Cr ₹479 Cr ₹504 Cr ₹487 Cr ₹409 Cr ₹621 Cr ₹848 Cr
Other Income ₹79 Cr ₹95 Cr ₹86 Cr ₹81 Cr ₹66 Cr ₹113 Cr ₹80 Cr ₹88 Cr
Interest ₹2 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹95 Cr ₹95 Cr ₹95 Cr ₹93 Cr ₹87 Cr ₹87 Cr ₹86 Cr ₹84 Cr
Profit Before Tax ₹713 Cr ₹489 Cr ₹469 Cr ₹492 Cr ₹466 Cr ₹435 Cr ₹615 Cr ₹852 Cr
Profit After Tax ₹538 Cr ₹358 Cr ₹348 Cr ₹356 Cr ₹321 Cr ₹306 Cr ₹493 Cr ₹702 Cr
EPS ₹20.30 ₹13.51 ₹13.13 ₹13.43 ₹12.11 ₹11.55 ₹18.60 ₹26.45
Industry Peers & Returns1W1M1Y
DIVIS LABORATORIES 0.5% -0.4% 24.7%
SUN PHARMACEUTICAL INDUSTRIES -0% 5% 47.2%
CIPLA 0.3% -1.8% 47.2%
DR REDDYS LABORATORIES 3.2% 11.5% 30.2%
ZYDUS LIFESCIENCES 1.9% 9% 100.9%
MANKIND PHARMA 2.1% -4.1% 24.2%
TORRENT PHARMACEUTICALS 0.5% 2.7% 52%
LUPIN 1.1% 14.1% 96.9%
AUROBINDO PHARMA 3.1% 9.5% 80.3%

DIVIS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

24.15 %

Y-o-Y

18.04 %

Quarters Revenues % Change
Mar2024 ₹2,303 Cr
24.15
Dec2023 ₹1,855 Cr
-2.83
Sep2023 ₹1,909 Cr
7.37
Jun2023 ₹1,778 Cr
-8.87
Mar2023 ₹1,951 Cr
14.23
Dec2022 ₹1,708 Cr
-7.92
Sep2022 ₹1,855 Cr
-17.74
Jun2022 ₹2,255 Cr -

DIVIS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

49.49 %

Y-o-Y

50.10 %

Quarters Operating Profit % Change
Mar2024 ₹731 Cr
49.49
Dec2023 ₹489 Cr
2.09
Sep2023 ₹479 Cr
-4.96
Jun2023 ₹504 Cr
3.49
Mar2023 ₹487 Cr
19.07
Dec2022 ₹409 Cr
-34.14
Sep2022 ₹621 Cr
-26.77
Jun2022 ₹848 Cr -
Operating Margins
Q-o-Q

20.41 %

Y-o-Y

27.16 %

Quarters Operating Margin% % Change
Mar2024 31.74%
20.41
Dec2023 26.36%
5.06
Sep2023 25.09%
-11.50
Jun2023 28.35%
13.58
Mar2023 24.96%
4.22
Dec2022 23.95%
-28.46
Sep2022 33.48%
-10.98
Jun2022 37.61% -

DIVIS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

50.28 %

Y-o-Y

67.60 %

Quarters Profit After Tax % Change
Mar2024 ₹538 Cr
50.28
Dec2023 ₹358 Cr
2.87
Sep2023 ₹348 Cr
-2.25
Jun2023 ₹356 Cr
10.90
Mar2023 ₹321 Cr
4.90
Dec2022 ₹306 Cr
-37.93
Sep2022 ₹493 Cr
-29.77
Jun2022 ₹702 Cr -
PAT Margins
Q-o-Q

21.04 %

Y-o-Y

42.01 %

Quarters PAT Margin(%) % Change
Mar2024 23.36 %
21.04
Dec2023 19.3 %
5.87
Sep2023 18.23 %
-8.94
Jun2023 20.02 %
21.70
Mar2023 16.45 %
-8.20
Dec2022 17.92 %
-32.58
Sep2022 26.58 %
-14.62
Jun2022 31.13 % -

DIVIS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

50.26 %

Y-o-Y

67.63 %

Quarters EPS % Change
Mar2024 ₹20.3
50.26
Dec2023 ₹13.51
2.89
Sep2023 ₹13.13
-2.23
Jun2023 ₹13.43
10.90
Mar2023 ₹12.11
4.85
Dec2022 ₹11.55
-37.90
Sep2022 ₹18.6
-29.68
Jun2022 ₹26.45 -

You may also like the below Video Courses